期刊文献+

高龄(≥70岁)早期非小细胞肺癌胸腔镜术后生存的预后因素分析 被引量:18

Analysis on Prognostic Factors of Long-term Outcomes in Elderly Patients with Early-stage NSCLC Treated by Video-assisted Thoracoscopic Surgery
下载PDF
导出
摘要 目的 探讨影响高龄(≥70岁)Ⅰ期非小细胞肺癌(non—small cell lungcancer,NSCLC)患者术后生存的预后因素。方法回顾性分析2003年4月~2013年12月我院211例70岁及以上I期NSCLC的临床及随访资料,对影响术后生存的预后因素采用Kaplan.Meier生存分析、log-rank检验及Cox回归分析。结果中位随访时间39个月(0~93个月)。5年总生存率为66.9%,Kaplan—Meier生存分析和Cox单因素回归分析显示病变部位、病理分期、病变直径、分化程度、查尔森合并症指数(Chalsoncomorbidityindex,ccI)对总生存期存在影响。Cox多因素回归分析显示:病变部位(HR=3.946,95%C11.571~9.910)、病理分化(HR=2.003,95%C11.049—3.824)、肿瘤直径(HR=2.841,95%C11.478~5.462)及CCI(HR:3.920,95%CI1.767~8.698)是影响高龄早期肺癌患者术后生存的独立预后因素。结论对于早期高龄NSCLC患者,CCI、病变部位、分化程度、肿瘤直径是影响术后生存的重要预后因素。CCI对长期生存预后有一定的价值。加强术前综合评估有利于指导预后。 Objective To investigate prognostic factors of long-term survival in elderly patients with stage I non-small cell lung cancer (NSCLC). Methods We conducted a retrospective review of clinical and follow-up data of 211 patients aged ≥70 years old with stage [ NSCLC April 2003 to December 2013 in our department. The Kaplan-Meier survival analysis, log-rank test,and Cox regression analysis were carried out to investigate the prognostic factors. Results The median follow-up time was 39 months (range, 0 - 93 months). The 5-year overall survival rate was 66. 9%. The Kaplan-Meier survival analysis and Cox univariate regression analysis indicated that tumor location,pathological stage, tumor size, pathological differentiation, Chalson comorbidity index (CCI) were correlated to overall survival. The Cox muhivariate analysis demonstrated that tumor location ( HR = 3. 946, 95% CI 1.571 -9.910) , pathological differentiation (HR = 2. 003, 95% CI 1. 049 - 3. 824), tumor size (HR = 2. 841, 95% CI 1. 478 - 5. 462) , and CCI (HR = 3. 920, 95% C1 1. 767 - 8. 698) were independent prognostic factors of postoperative long-term outcomes in elderly patients with early stage NSCLC. Conclusions For elderly patients with stage I NSCLC, the CCI, tumor location, pathological differentiation, and tumor size predicts a long-term survival. The CCI is of important value for predicting a long-term survival. Comprehensive preoperative assessment may benefit the prognostic estimation.
出处 《中国微创外科杂志》 CSCD 北大核心 2016年第2期97-100,105,共5页 Chinese Journal of Minimally Invasive Surgery
基金 首都卫生发展科研专项项目(首发2014-1-4081)
关键词 肺癌 预后 高龄 早期 查尔森合并症指数 Lung cancer Prognosis Elderly Early stage Chalson comorbidity index
  • 相关文献

参考文献23

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin, 2015, 65(1): 5-29.
  • 2National Lung Screening Trial Research Team. Reduced lung-cam:er mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395 -409.
  • 3Blanco R, Maestu 1, de la Torre MG, et al. A review of tl~e management of elderly patients with non-small-ce|l lung cancer, Ann Oncol, 2015, 26(3): 451 -463.
  • 4Rocco G, Weder W. Lung surgery in the eh|erly Ioday. Lung Cancer, 2013, 80(2): 115-119.
  • 5李运,王俊,隋锡朝,卜梁,周足力,刘彦国,杨帆,赵辉,姜冠潮,李剑锋,刘军.全胸腔镜肺叶切除手术操作流程及技巧的优化:北京大学人民医院经验[J].中华胸心血管外科杂志,2010,26(5):300-306. 被引量:81
  • 6World Health Organization. Guidelines for controlling and monitoring the tobaeco epidemic. World Health Organization, 1998. 63 - 64.
  • 7Travis WD. The 20]5 WHO elassifiealion of lung I~mmrs. Pathologe, 2014, 35(Supp12): 188.
  • 8Valli~res E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung t~ancer. J Thnrae Oncol, 2009, 4(9) : 1049 - 1059.
  • 9Charlson ME, Pompei P, Ales KL, et al. A new method of elassifying prognostic eomorbidity in longitudinal studies : development and validation. J Chronie Dis, 1987,40 (5) : 373 - 383.
  • 10Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg, 2005, 28 (5) : 759 - 762.

二级参考文献60

  • 1Goldstraw P, Crowley JJ; On behalf of the IASLC International Staging Project. The international association for the study of lung cancer international staging project on lung cancer. J Thorac Oncol 2006; 1:281-286.
  • 2Rami-Porta R, Ball D, Crowley JJ, et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM cJassification for lung cancer. J Thorac Oncol 2007;2:593- 602.
  • 3Kusch VW, Crowley JJ, Giroux DJ, et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM dassification for lung cancer. J Thorac Oncol 2007;2:603- 612.
  • 4Postmus PE, Brambilla E, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007;2:686-693.
  • 5Goldstraw P, Crowley JJ, Chansky K, et al. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;8:706 - 714.
  • 6Sculier Jp, Chansky K, CrowleyJJ, et al. International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol 2008;3:4,57- 466.
  • 7Groome PA, Bolejack V, Crowley JJ, et al. IASLC International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC lung cancer staging project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694 -705.
  • 8Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological Typing of Lung and Pleural Tumors, 3rd Ed. Berlin: Springer, 1999.
  • 9Crowley JJ, Leblanc M, Jacobson J, Salmon S. Some Exploratory Tools for Survival Analysis. In Lin DY, Fleming TR, (Eds.), New York: Springer, 1997.
  • 10Cancer Statistics Branch Surveillance Program DCCPS. The SEEK Program Code Manual, 3rd Ed. Bethesda, MD: National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, 1998.

共引文献100

同被引文献168

引证文献18

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部